I don’t think it was that controversial to short a stock like VUL which had well overshot fair value for it’s stage. At the end of the day people can either agree or disagree with the thesis. There’s little point in mounting a case unless they can back it up.
What they are saying on FFX is what we all have been...criminally undervalued given the stage of development, fully financed and production numbers to come.
SP Target = $1.80 - $2.25 from memory. You disagree? Then there’s stage 2 Goulamina to send it further North
FFX Price at posting:
88.5¢ Sentiment: Buy Disclosure: Held
